|
1 Generation of Transgenic Animals Using Lentiviral Vectors |
|
|
1 | (22) |
|
|
|
|
1 | (2) |
|
1.2 The Production of Lentiviral Vectors |
|
|
3 | (9) |
|
1.2.1 Design and Construction of the Lentiviral Transfer Vector |
|
|
3 | (1) |
|
|
4 | (1) |
|
|
4 | (2) |
|
1.2.4 Plasmid Preparation |
|
|
6 | (1) |
|
1.2.5 Preparation of 293T Cells |
|
|
6 | (2) |
|
|
8 | (2) |
|
1.2.7 Viral Concentration |
|
|
10 | (2) |
|
|
12 | (1) |
|
1.3 Production of Transgenic Mice and Rats |
|
|
12 | (6) |
|
1.3.1 Superovulation and Embryo Collection |
|
|
13 | (1) |
|
1.3.2 Delivery of Lentiviruses to Single-Cell Embryos |
|
|
14 | (3) |
|
1.3.3 Transfer of Embryos into Recipient Females |
|
|
17 | (1) |
|
1.4 Establishment of Stable Strains from Lentiviral Founder Animals |
|
|
18 | (1) |
|
1.4.1 Mating of Founder Animals |
|
|
18 | (1) |
|
1.5 Safety Guidelines for Pseudotyped Retroviruses |
|
|
19 | (2) |
|
|
21 | (2) |
|
2 Intracytoplasmic Sperm Injection (ICSI) in the Mouse |
|
|
23 | (18) |
|
Ming-Wen Li, K.C. Kent Lloyd |
|
|
|
2.1 General Description of Intracytoplasmic Sperm Injection (ICSI) |
|
|
23 | (1) |
|
|
24 | (1) |
|
2.3 Quality and Treatment of Sperm Used for ICSI |
|
|
25 | (1) |
|
|
26 | (1) |
|
2.5 Preparation of Microtools |
|
|
27 | (1) |
|
|
28 | (1) |
|
|
29 | (8) |
|
2.7.1 Preparation of Sperm |
|
|
29 | (1) |
|
2.7.2 Preparation of Oocytes |
|
|
29 | (1) |
|
2.7.3 Injection Procedure |
|
|
30 | (2) |
|
|
32 | (3) |
|
|
35 | (2) |
|
|
37 | (1) |
|
2.9 Reasonable Cautions and Concerns Regarding ICSI |
|
|
38 | (1) |
|
|
38 | (3) |
|
3 Generation of Embryonic Stem (ES) Cell-Derived Embryos and Mice by Tetraploid-Embryo Complementation |
|
|
41 | (28) |
|
Kevin Eggan, Rudolf Jaenisch |
|
|
|
|
41 | (7) |
|
3.1.1 Advantages of Using Tetraploid Embryo Complementation |
|
|
44 | (4) |
|
|
48 | (4) |
|
3.2.1 Derivation, Culture and in vitro Gene Targeting of F1 ES Cells |
|
|
48 | (2) |
|
3.2.2 Sub-cloning of ES Cells to Identify 39X0 Derivatives of Targeted Cell Lines |
|
|
50 | (1) |
|
3.2.3 Y Chromosome Genotyping by Southern Hybridization |
|
|
50 | (1) |
|
3.2.4 Identification of 39X0 Subclones by PCR |
|
|
51 | (1) |
|
3.2.5 Karyotyping of ES Cell Lines during Serial Gene Targeting |
|
|
52 | (1) |
|
3.3 Production of Tetraploid Embryos |
|
|
52 | (14) |
|
3.3.1 Isolation and In Vitro Culture of Preimplantation Embryos |
|
|
53 | (1) |
|
3.3.2 Electrofusion of Two-cell Embryos |
|
|
54 | (2) |
|
3.3.3 Electrofusion by AC Alignment and DC Pulse |
|
|
56 | (1) |
|
3.3.4 Manual Alignment and DC Fusion of Two-cell Embryos |
|
|
57 | (1) |
|
3.3.5 Culture of Tetraploid Embryos to Blastocyst Stage |
|
|
58 | (1) |
|
3.3.6 Microscope Set-up for Microinjection |
|
|
58 | (2) |
|
3.3.7 Preparation of Microinjection Instruments for Piezo Microinjection |
|
|
60 | (2) |
|
3.3.8 Piezo-Micromanipulator Injection of Tetraploid Blastocysts with ES Cells |
|
|
62 | (2) |
|
3.3.9 Embryo Transfer to Recipient Females |
|
|
64 | (2) |
|
3.3.10 Cesarian Section and Cross Fostering of ES Cell Tetraploid Mice |
|
|
66 | (1) |
|
|
66 | (1) |
|
|
67 | (2) |
|
4 Cloning The Laboratory Mouse by Nuclear Transfer |
|
|
69 | (28) |
|
Kevin Eggan, Rudolf Jaenisch |
|
|
|
|
69 | (2) |
|
4.2 Factors Influencing Cloning Success |
|
|
71 | (5) |
|
4.2.1 Cell Cycle Status of the Donor Cell |
|
|
72 | (1) |
|
4.2.2 Genetic Influences on the Cloning Process |
|
|
72 | (2) |
|
4.2.3 Intrinsic Developmental Potential of the Donor Cell |
|
|
74 | (1) |
|
4.2.4 Cellular Identity of the Donor Cell |
|
|
74 | (1) |
|
4.2.5 Epigenetic Reprogramming after Nuclear Transfer |
|
|
75 | (1) |
|
4.3 Methods, Equipment and Techniques |
|
|
76 | (9) |
|
4.3.1 Embryo Culture Media and Common Stock Solutions |
|
|
76 | (1) |
|
4.3.2 Mouse Strains and Animal Husbandry |
|
|
77 | (1) |
|
4.3.3 Preparation of Cumulus Cells for Nuclear Transfer |
|
|
77 | (1) |
|
4.3.4 Preparation of Tail-tip Cells for Nuclear Transfer |
|
|
77 | (1) |
|
4.3.5 Culture and Preparation of ES donor cells for Nuclear Transfer |
|
|
78 | (1) |
|
|
78 | (1) |
|
4.3.7 Micromanipulation Instruments for Nuclear Transfer |
|
|
78 | (1) |
|
4.3.8 Isolation of Metaphase II Oocytes for Nuclear Transfer |
|
|
79 | (1) |
|
4.3.9 Enucleation of MII Oocytes |
|
|
80 | (1) |
|
|
80 | (1) |
|
4.3.11 Oocyte Activation and Subsequent Culture of Cloned Embryos |
|
|
80 | (3) |
|
4.3.12 Derivation of Nuclear Transfer ES Cells |
|
|
83 | (1) |
|
4.3.13 Embryo Transfer of Cloned Embryos |
|
|
84 | (1) |
|
4.3.14 Cesarean Section and Cross Fostering of Cloned Animals |
|
|
85 | (1) |
|
4.4 Protocol for Direct Injection Nuclear Transfer |
|
|
85 | (9) |
|
4.4.1 Production of Embryo Culture Medium, Reagents and Mice |
|
|
85 | (3) |
|
4.4.2 Oocyte (Egg) Collection |
|
|
88 | (2) |
|
|
90 | (2) |
|
4.4.4 Donor Nucleus Isolation |
|
|
92 | (1) |
|
|
93 | (1) |
|
4.4.6 Oocyte Activation and Long-Term Culture |
|
|
94 | (1) |
|
|
94 | (3) |
|
5 Large Insert Transgenesis |
|
|
97 | (14) |
|
Shiaoching Gong, Nat Heintz |
|
|
|
|
97 | (2) |
|
5.2 Highly Efficient BAC Modification Based on the R6Kγ Origin of Replication |
|
|
99 | (2) |
|
5.3 An Approach to High Throughput Studies |
|
|
101 | (7) |
|
5.3.1 A Precisely Modified BAC Clone for Use in the Production of Transgenic Mice (Protocol 1) |
|
|
101 | (4) |
|
5.3.2 Preparation of BAC DNA by Double Acetate Precipitation and CsC1 Gradient Centrifugation (Protocol 2) |
|
|
105 | (3) |
|
5.3.3 Injection of BAC DNA |
|
|
108 | (1) |
|
|
108 | (1) |
|
|
108 | (1) |
|
|
109 | (1) |
|
|
109 | (2) |
|
6 Regional and Temporal Control of Genetic Manipulation in the Mouse |
|
|
111 | (20) |
|
Mansuo L. Hayashi, Shigemi Hayashi |
|
|
|
|
111 | (1) |
|
|
111 | (12) |
|
|
111 | (1) |
|
|
112 | (2) |
|
6.2.3 Generating Cre lines |
|
|
114 | (1) |
|
6.2.4 Genotyping Cre Lines |
|
|
115 | (1) |
|
6.2.5 Screening Cre Lines |
|
|
115 | (3) |
|
6.2.6 Generating Floxed Lines |
|
|
118 | (1) |
|
6.2.7 RNA in situ Hybridization |
|
|
119 | (3) |
|
6.2.8 Tyramide Signal Amplification (TSA) for Fluorescence Immunostaining |
|
|
122 | (1) |
|
6.2.9 The Temporally Controllable Cre-loxP System |
|
|
122 | (1) |
|
6.3 The Tetracycline Regulatory System |
|
|
123 | (5) |
|
|
123 | (1) |
|
|
124 | (1) |
|
6.3.3 Generating tTA/rtTA Regulator Lines |
|
|
125 | (1) |
|
6.3.4 Genotyping tTA/rtTA Regulator Lines |
|
|
126 | (1) |
|
6.3.5 Screening tTA/rtTA Regulator Lines |
|
|
126 | (1) |
|
6.3.6 Generating tet-Responsive Lines |
|
|
127 | (1) |
|
6.3.7 Genotyping tet-Responsive Lines |
|
|
127 | (1) |
|
6.3.8 Screening tet-Responsive Lines |
|
|
127 | (1) |
|
6.4 New Directions for Regional and Temporal Gene Manipulation |
|
|
128 | (1) |
|
|
129 | (2) |
|
7 High Resolution Gene Expression Analysis Using Reporter Genes |
|
|
131 | (42) |
|
Niels C. Adams, Nicholas W. Gale |
|
|
|
|
131 | (2) |
|
|
133 | (8) |
|
7.2.1 Selection of the Appropriate Reporter Gene |
|
|
133 | (3) |
|
7.2.2 Placental Alkaline Phosphatase |
|
|
136 | (2) |
|
|
138 | (3) |
|
|
141 | (1) |
|
|
141 | (1) |
|
|
142 | (17) |
|
|
142 | (1) |
|
7.4.2 Dissection of Embryos for Whole-mount Staining for β-Gal or PLAP visualization |
|
|
142 | (3) |
|
7.4.3 Whole-mount Staining of Embryos for LacZ |
|
|
145 | (2) |
|
7.4.4 Whole-mount PLAP Staining of Embryos |
|
|
147 | (1) |
|
7.4.5 Dissection of Adult Tissue |
|
|
148 | (3) |
|
7.4.6 Preparing Embryos and Adult Tissues for Cryo-Sectioning |
|
|
151 | (2) |
|
|
153 | (2) |
|
7.4.8 Whole-mount Adult LacZ Staining |
|
|
155 | (1) |
|
7.4.9 Enhancements to the Standard LacZ Staining Protocol |
|
|
156 | (1) |
|
|
157 | (2) |
|
|
159 | (2) |
|
|
161 | (12) |
|
8 Nuclear Transfer in the Cow |
|
|
173 | (22) |
|
|
|
|
173 | (1) |
|
|
174 | (4) |
|
|
174 | (1) |
|
|
175 | (1) |
|
8.2.3 Manipulation Chamber |
|
|
176 | (1) |
|
|
176 | (1) |
|
|
177 | (1) |
|
|
177 | (1) |
|
|
177 | (1) |
|
|
178 | (5) |
|
|
178 | (1) |
|
8.3.2 Dissection Medium (50 ml) |
|
|
178 | (1) |
|
|
178 | (1) |
|
8.3.4 Stock solution B (250 mM NaHCO3) |
|
|
178 | (1) |
|
8.3.5 Stock solution C (33 mM pyruvate) |
|
|
179 | (1) |
|
8.3.6 Stock solution D (171 mM CaCl2.2H2O) |
|
|
179 | (1) |
|
8.3.7 Stock solution G (60 mM Glucose) |
|
|
179 | (1) |
|
8.3.8 Stock solution GLN (10 mM L-Glutamine) |
|
|
179 | (1) |
|
8.3.9 Stock solution H (250 mM Hepes) |
|
|
180 | (1) |
|
8.3.10 Stock solution K (kanamycin sulphate) |
|
|
180 | (1) |
|
8.3.11 Stock solution L (330 mM Na lactate) |
|
|
180 | (1) |
|
8.3.12 Stock solution M (MgCl2- 6H20) |
|
|
180 | (1) |
|
|
181 | (1) |
|
8.3.14 Hepes synthetic oviduct fluid (hSOF) +Ca |
|
|
181 | (1) |
|
8.3.15 Hepes SOF (hSOF) -Ca |
|
|
182 | (1) |
|
8.3.16 Culture Medium (SOFaaBSA) |
|
|
182 | (1) |
|
|
183 | (1) |
|
|
183 | (8) |
|
|
184 | (1) |
|
8.4.2 Enucleation of Oocytes |
|
|
185 | (3) |
|
|
188 | (1) |
|
|
188 | (1) |
|
|
189 | (1) |
|
|
190 | (1) |
|
|
191 | (1) |
|
|
191 | (1) |
|
|
192 | (1) |
|
|
192 | (3) |
|
9 Production of Transgenic Pigs by DNA Microinjection |
|
|
195 | (26) |
|
Robert M. Petters, Rebecca L. Krisher |
|
|
|
|
195 | (2) |
|
9.1.1 In Vivo Produced Embryos |
|
|
195 | (1) |
|
9.1.2 In Vitro Produced Embryos |
|
|
196 | (1) |
|
9.2 Protocol for In Vitro Production of Pig Embryos |
|
|
197 | (15) |
|
9.2.1 Media, Solutions and Reagents |
|
|
197 | (7) |
|
|
204 | (1) |
|
9.2.3 Oocyte Collection and In Vitro Maturation (Day 1) |
|
|
204 | (3) |
|
9.2.4 In Vitro Fertilization |
|
|
207 | (4) |
|
|
211 | (1) |
|
9.3 Protocols for In Vivo Production of Pig Embryos |
|
|
212 | (3) |
|
9.3.1 Media, Solutions and Reagents |
|
|
212 | (1) |
|
|
212 | (1) |
|
9.3.3 Synchronization and Superovulation of Embryo Donors |
|
|
212 | (1) |
|
|
213 | (2) |
|
9.4 Production of Transgenic Pigs |
|
|
215 | (4) |
|
9.4.1 Centrifugation and Microinjection of Embryos |
|
|
215 | (2) |
|
9.4.2 Embryo Recipient Selection and Embryo Transfer |
|
|
217 | (1) |
|
9.4.3 Methods for Animal Identification |
|
|
218 | (1) |
|
|
219 | (2) |
10 Production of Transgenic Birds Using Lentiviral Vectors |
|
221 | (10) |
|
Benjamin B. Scott, Carlos Lois |
|
|
|
|
221 | (1) |
|
10.2 Overview of the Strategy |
|
|
222 | (1) |
|
10.3 Design of Lentiviral Vectors for Transgene Expression |
|
|
222 | (3) |
|
|
222 | (2) |
|
|
224 | (1) |
|
10.4 Production of Transgenic Birds |
|
|
225 | (4) |
|
|
225 | (1) |
|
10.4.2 Injection for the Production of Mosaic Founders (FO) |
|
|
226 | (2) |
|
10.4.3 Transgenic Offspring |
|
|
228 | (1) |
|
|
228 | (1) |
|
|
229 | (2) |
11 Ancillary Techniques |
|
231 | (46) |
|
|
|
|
231 | (1) |
|
|
231 | (6) |
|
11.2.1 Microinjection Equipment |
|
|
232 | (1) |
|
11.2.2 Mouse Stocks for Embryo Production and Implantation |
|
|
233 | (3) |
|
11.2.3 Rat Stocks for Embryo Production and Implantation |
|
|
236 | (1) |
|
11.3 Embryo Production in Rats and Mice |
|
|
237 | (10) |
|
11.3.1 Preparation of Hormones and Enzymes |
|
|
240 | (1) |
|
11.3.2 Hormone Priming of Mice |
|
|
240 | (1) |
|
11.3.3 Hormone Priming of Rats |
|
|
241 | (2) |
|
11.3.4 Embryo Collection and Culture in Mice |
|
|
243 | (3) |
|
11.3.5 Embryo Collection and Culture in Rats |
|
|
246 | (1) |
|
11.4 Transfer of Mouse and Rat Embryos |
|
|
247 | (11) |
|
11.4.1 Synchronization and Implantation of Recipient Mice |
|
|
247 | (2) |
|
11.4.2 Oviduct Transfers in Mice: Unilateral, Infundibulum or Ampulla |
|
|
249 | (5) |
|
11.4.3 Uterine Transfers in Mice |
|
|
254 | (2) |
|
11.4.4 Synchronization and Embryo Transfer in Recipient Rats |
|
|
256 | (1) |
|
11.4.5 Oviduct Implants in Rats, by Infundibulum or Ampulla |
|
|
257 | (1) |
|
|
258 | (9) |
|
11.5.1 Commonly used ES Cell Lines |
|
|
258 | (5) |
|
11.5.2 Elementary Karyotyping |
|
|
263 | (4) |
|
11.6 The Establishment of Stable Strains from Genetically Altered Animals |
|
|
267 | (7) |
|
11.6.1 Breeding from Chimeric Mice |
|
|
267 | (5) |
|
11.6.2 Breeding from Lentiviral Founder Animals |
|
|
272 | (2) |
|
|
274 | (3) |
Subject Index |
|
277 | |